Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$10.87
+2.07%
Mkt Cap $13.31M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$31.50
Range $25.00 – $40.00
Implied Upside
+189.8%
Consensus $31.50 vs current $10.87
NASDAQ·Healthcare·Biotechnology
$10.87
+2.07%
Mkt Cap $13.31M
No recent rating data.
Price Target (7 analysts)
$31.50
Range $25.00 – $40.00
+189.8%
Consensus $31.50 vs current $10.87